Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival
ConclusionsOur study determined that MBC patients possessed a worse prognosis, usually with lymph node invasion, and were estrogen receptor (ER), progesterone receptor (PR) ‐positive and human epidermal growth factor receptor (HER2)‐negative. Molecular subtypes based on FBC did not provide the same prognostic information in MBC, even in the luminal groups.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Jing Zhao,
Bin Wang,
Jing Zhao,
Yiran Mao,
Jun Liu,
Yanfang Yang Tags: ORIGINAL ARTICLE Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | HER2 | Hormones | Male Breast Cancer | Mastectomy | Molecular Biology | Study